This research is based on a research study commissioned by the Office of the Assistant Secretary for Planning and Evaluation (ASPE), Department of Health and Human Services (HHS). Ariel Dora Stern is supported by a Junior Faculty Fellowship from the Kauffman Foundation. The other authors report no additional financial support for this research. Any opinions presented in this article are those of the authors only and do not represent the views of their employers. Mark Trusheim reports receiving other income from Co-Bio Consulting LLC. Amber Jessup’s contributions to study design and writing primarily occurred when she worked at ASPE. The views expressed in this article are those of the authors and do not necessarily represent those of the Office of the Assistant Secretary for Planning and Evaluation or the Office of Inspector General, Department of Health and Human Services.
"follow" - Google News
June 08, 2021 at 02:46AM
https://ift.tt/3crVXIP
Biosimilars And Follow-On Products In The United States: Adoption, Prices, And Users - healthaffairs.org
"follow" - Google News
https://ift.tt/35pbZ1k
https://ift.tt/35rGyU8
Bagikan Berita Ini
0 Response to "Biosimilars And Follow-On Products In The United States: Adoption, Prices, And Users - healthaffairs.org"
Post a Comment